In the Media

Writing for Forbes, Joseph Coughlin, director of the AgeLab, explores the question of whether microchip tracking technology could potentially become widely accepted. “Such technology forces us to prioritize the value we assign to personal independence and freedom versus the promise of safety and wellbeing,” writes Coughlin.